-
On January 14, 2013, that the U.S. FDA approved a device allowing detection of multiple gastrointestinal pathogens from a single sample of feces.
-
A surgeon reported having suffered a sharps injury while performing an orthopedic procedure. Baseline testing found no evidence of HBV infection in the source patient, but determined that the surgeon had preexisting HBV infection, with positive HBsAg, positive HBeAg, negative IgM anti-HBc, and normal serum hepatic transaminases.
-
An analysis was performed of incident cases of tuberculosis in the United States reported to the Centers for Disease Control and Prevention from 2008-2010.
-
In the United States, approximately 50% of individuals develop antibodies to Epstein-Barr virus (EBV) by age 5.
-
A large outbreak of community acquired pneumonia due to macrolide-resistant M. pneumoniae (MRMP) occurred in Japan in 2011 and mainly affected school-age children.
-
In this issue: Apixaban approval; new dental clinical practice guideline; apixaban for VTE; aspirin resistance; tamoxifen treatment; and FDA actions.
-
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions.
-
-
Crossing the border with highly resistant TB; Fecal Transplant Centers are growing in 'poopularity'; Bedbug Detection Squad
-
Q fever is prevalent in farm animals, which are the prime source of infection. The diagnosis of Q fever generally requires a high index of suspicion and a depth of knowledge of serological and other methods of detection.